MicroRNAs in Renal Cell Carcinoma: a Systematic Review of Clinical Implications (Review)

Overview

Journal Oncol Rep

Specialty Oncology

Date 2015 Feb 17

PMID 25682771

Citations 38

Authors

Ming Li

Ying Wang

Yongsheng Song

Renge Bu

Bo Yin

Xiang Fei

Qizhen Guo

Bin Wu

Affiliations

Soon will be listed here.

Abstract

Despite recent advances in the understanding of the biology of renal cell carcinoma (RCC), successful surgical treatment and implementation of novel‑targeted therapies, the prognosis for RCC patients remains poor. Late presentation, tumor heterogeneity and in particular the lack of molecular biomarkers for early detection, classification and the surveillance of RCC treatments are major obstacles. The increasing knowledge regarding the functional role of microRNAs (miRNAs) in pathophysiological processes may provide an important link to the identification of suitable therapeutic targets and diagnostic/prognostic biomarkers for RCC. The aim of this review was to provide new insight into the function of miRNAs in the pathogenesis of RCC and to emphasize their potential as diagnostic and prognostic markers, as well as therapeutic targets.

Citing Articles

Shikonin Causes an Apoptotic Effect on Human Kidney Cancer Cells through Ras/MAPK and PI3K/AKT Pathways.

Kiraly J, Szabo E, Fodor P, Fejes Z, Nagy Jr B, Juhasz E Molecules. 2023; 28(18).

PMID: 37764501 PMC: 10534756. DOI: 10.3390/molecules28186725.

Druggable Biomarkers Altered in Clear Cell Renal Cell Carcinoma: Strategy for the Development of Mechanism-Based Combination Therapy.

Rustum Y, Reis R, Rustum T Int J Mol Sci. 2023; 24(2).

PMID: 36674417 PMC: 9864911. DOI: 10.3390/ijms24020902.

Oncogenic Role of miR-217 During Clear Cell Renal Carcinoma Progression.

Zamora-Fuentes J, Hernandez-Lemus E, Espinal-Enriquez J Front Oncol. 2022; 12:934711.

PMID: 35936681 PMC: 9354686. DOI: 10.3389/fonc.2022.934711.

MicroRNA Expression in Clear Cell Renal Cell Carcinoma Cell Lines and Tumor Biopsies: Potential Therapeutic Targets.

Swearson S, Rataan A, Eliason S, Amendt B, Zakharia Y, Salem A Int J Mol Sci. 2022; 23(10).

PMID: 35628416 PMC: 9147802. DOI: 10.3390/ijms23105604.

MicroRNA-196a promotes renal cancer cell migration and invasion by targeting BRAM1 to regulate SMAD and MAPK signaling pathways.

Cui J, Yuan Y, Shanmugam M, Anbalagan D, Tan T, Sethi G Int J Biol Sci. 2021; 17(15):4254-4270.

PMID: 34803496 PMC: 8579441. DOI: 10.7150/ijbs.60805.

References

Dey N, Das F, Ghosh-Choudhury N, Mandal C, Parekh D, Block K . microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion. PLoS One. 2012; 7(6):e37366. PMC: 3368259. DOI: 10.1371/journal.pone.0037366. View

Xu X, Wu J, Li S, Hu Z, Xu X, Zhu Y . Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway. Mol Cancer. 2014; 13:109. PMC: 4040501. DOI: 10.1186/1476-4598-13-109. View

Yamasaki T, Seki N, Yoshino H, Itesako T, Hidaka H, Yamada Y . MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway. J Urol. 2013; 190(3):1059-68. DOI: 10.1016/j.juro.2013.02.089. View

Schiffgen M, Schmidt D, von Rucker A, Muller S, Ellinger J . Epigenetic regulation of microRNA expression in renal cell carcinoma. Biochem Biophys Res Commun. 2013; 436(1):79-84. DOI: 10.1016/j.bbrc.2013.05.061. View

Zhao J, Lei T, Xu C, Li H, Ma W, Yang Y . MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3. Biochem Biophys Res Commun. 2013; 438(2):439-44. DOI: 10.1016/j.bbrc.2013.07.095. View

Lin J, Horikawa Y, Tamboli P, Clague J, Wood C, Wu X . Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma. Carcinogenesis. 2010; 31(10):1805-12. PMC: 2981457. DOI: 10.1093/carcin/bgq168. View

Lee Y, Kim M, Han J, Yeom K, Lee S, Baek S . MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004; 23(20):4051-60. PMC: 524334. DOI: 10.1038/sj.emboj.7600385. View

Kawakami K, Enokida H, Chiyomaru T, Tatarano S, Yoshino H, Kagara I . The functional significance of miR-1 and miR-133a in renal cell carcinoma. Eur J Cancer. 2011; 48(6):827-36. DOI: 10.1016/j.ejca.2011.06.030. View

Shinmei S, Sakamoto N, Goto K, Sentani K, Anami K, Hayashi T . MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma. Int J Urol. 2012; 20(5):468-77. DOI: 10.1111/j.1442-2042.2012.03182.x. View

10.

von Brandenstein M, Pandarakalam J, Kroon L, Loeser H, Herden J, Braun G . MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples. Am J Pathol. 2012; 180(5):1787-97. DOI: 10.1016/j.ajpath.2012.01.014. View

11.

Cohen H, McGovern F . Renal-cell carcinoma. N Engl J Med. 2005; 353(23):2477-90. DOI: 10.1056/NEJMra043172. View

12.

Zaman M, Thamminana S, Shahryari V, Chiyomaru T, Deng G, Saini S . Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PLoS One. 2012; 7(11):e50203. PMC: 3506541. DOI: 10.1371/journal.pone.0050203. View

13.

Lichner Z, Mejia-Guerrero S, Ignacak M, Krizova A, Bao T, Girgis A . Pleiotropic action of renal cell carcinoma-dysregulated miRNAs on hypoxia-related signaling pathways. Am J Pathol. 2012; 180(4):1675-87. DOI: 10.1016/j.ajpath.2011.12.030. View

14.

Wang J, He J, Su F, Ding N, Hu W, Yao B . Repression of ATR pathway by miR-185 enhances radiation-induced apoptosis and proliferation inhibition. Cell Death Dis. 2013; 4:e699. PMC: 3702279. DOI: 10.1038/cddis.2013.227. View

15.

Chen B, Duan L, Yin G, Tan J, Jiang X . miR-381, a novel intrinsic WEE1 inhibitor, sensitizes renal cancer cells to 5-FU by up-regulation of Cdc2 activities in 786-O. J Chemother. 2013; 25(4):229-38. DOI: 10.1179/1973947813Y.0000000092. View

16.

Li S, Chen T, Zhong Z, Wang Y, Li Y, Zhao X . microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells. Mol Med Rep. 2012; 5(4):949-54. PMC: 3493052. DOI: 10.3892/mmr.2012.779. View

17.

Wang X, Chen X, Wang R, Xiao P, Xu Z, Chen L . microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis. Oncol Rep. 2013; 30(2):643-50. DOI: 10.3892/or.2013.2530. View

18.

Wu D, Pan H, Zhou Y, Zhou J, Fan Y, Qu P . microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma. Mol Med Rep. 2014; 9(6):2491-8. DOI: 10.3892/mmr.2014.2116. View

19.

Redova M, Poprach A, Nekvindova J, Iliev R, Radova L, Lakomy R . Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med. 2012; 10:55. PMC: 3340316. DOI: 10.1186/1479-5876-10-55. View

20.

Bullock A, Mcdermott D, Atkins M . Management of metastatic renal cell carcinoma in patients with poor prognosis. Cancer Manag Res. 2010; 2:123-32. PMC: 3004580. View